Clinical trial

Imaging Depression in Parkinson's Disease

NCT06402955

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-01

PhasePHASE2

Study timeline

Study start (actual)2024-09-01Date precision: day

Registry last updated2026-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseverified · MONDO: Parkinson disease

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

11C-UCB-JRADIATION

ketamine hydrochlorideDRUG · verified · RxNorm: ketamine hydrochloride

Sponsors & collaborators

Yale Universitylead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)collaborator

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06402955 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.